Korsana Biosciences Balance Sheet
NASDAQ: KRSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Korsana Biosciences financial position
At the end of fiscal 2025, Korsana Biosciences reported total assets of $10.0 million, up 4.3% from a year earlier against total liabilities of $900,000. Shareholders' equity stood at $9.1 million, or 91.0% of assets. The company held $3.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.15, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Korsana Biosciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.24M | 3.23M | 7.57M | 13.38M | 53.96M | 54.40M | 94.89M | 0 |
| Receivables | 1.00M | 556.00K | 0 | 96.00K | 100.00K | 0 | — | — |
| Total Current Assets | 4.63M | 4.22M | 8.02M | 14.82M | 55.46M | 58.50M | 101.20M | 879.00K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 65.00K | 6.87M | 11.61M | 6.50M |
| Total Assets | 9.98M | 9.57M | 13.37M | 18.08M | 59.33M | 115.38M | 186.48M | 7.40M |
| Accounts Payable | 508.00K | 390.00K | 1.20M | 2.97M | 1.83M | 1.15M | 3.23M | 2.78M |
| Short-Term Debt | — | — | — | 3.50M | 3.50M | 3.50M | — | — |
| Total Current Liabilities | 900.00K | 725.00K | 2.09M | 7.63M | 11.09M | 16.95M | 18.25M | 17.85M |
| Total Liabilities | 900.00K | 725.00K | 2.09M | 7.63M | 11.09M | 55.88M | 88.75M | 17.85M |
| Shareholders' Equity | 9.09M | 8.85M | 11.29M | 10.45M | 48.25M | 59.49M | 97.73M | -10.45M |
| Retained Earnings | -271.02M | -267.49M | -264.42M | -259.15M | -215.08M | -163.43M | -85.63M | — |
| Total Debt | — | — | — | 3.50M | 3.50M | 3.50M | — | — |
| Net Cash (Debt) | 3.24M | 3.23M | 7.57M | 9.88M | 50.46M | 50.90M | 94.89M | 0 |
| Shares Outstanding | 3.82M | 2.55M | 2.47M | 2.18M | 43.41M | 34.05M | 27.60M | 0 |
This table shows 8 annual periods of Korsana Biosciences's balance sheet, from FY 2025 back to FY 2018, across 14 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow KRSA's reporting calendar. What is a balance sheet?